In conclusion, the improvement of NAFLD by GLP-1RA involve different pathways including, on the one hand, an adaptation of plasma insulin and glucagon concentrations with a higher insulin sensitivity and, on the other hand, a decrease in AT lipotoxicity with weight-independent mechanisms [123]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.